Acalanib
Acalanib is a second-generation selective, irreversible Bruton’s tyrosine kinase inhibitor indicated for the treatment of CLL and mantle cell lymphoma.
Therapeutic Area
Onco-Hematology
Active Ingredient
Acalabrutinib
Line
Onco-hematology
Presentation:
Acalabrutinib 100 mg x 60 hard capsules
